De Stefano, Valerio
Rocca, Bianca
Tosetto, Alberto
Soldati, Denise
Petrucci, Giovanna
Beggiato, Eloise
Bertozzi, Irene
Betti, Silvia
Carli, Giuseppe
Carpenedo, Monica
Cattaneo, Daniele
Cavalca, Viviana
Dragani, Alfredo
Elli, Elena
Finazzi, Guido
Iurlo, Alessandra
Lanzarone, Giuseppe
Lissandrini, Laura
Palandri, Francesca
Paoli, Chiara
Rambaldi, Alessandro
Ranalli, Paola
Randi, Maria Luigia
Ricco, Alessandra
Rossi, Elena
Ruggeri, Marco
Specchia, Giorgina
Timillero, Andrea
Turnu, Linda
Vianelli, Nicola
Vannucchi, Alessandro M.
Rodeghiero, Francesco
Patrono, Carlo
Article History
Received: 15 February 2018
Revised: 23 March 2018
Accepted: 3 April 2018
First Online: 1 June 2018
Conflict of interest
: V.D.S. has received consulting and lecture fees from Amgen, Bayer, Celgene, Novartis, and institutional research grants from Novartis; B.R. has received consulting and lecture fees from Amgen, Bayer, Celgene, Daiichi Sankyo Italia, Novartis, and Sanofi; A.Ra. has received consulting and lecture fees from Amgen, Bristol Mayer Squibb, Celgene, Italfarmaco, Novartis, Pfizer, and Roche; F.P. has received consulting and lecture fees from Novartis; A.M.V. has received consulting and lecture fees from Italfarmaco, Novartis, Shire, and institutional research grants from Novartis; C.P. has received consulting and lecture fees from Amgen, AstraZeneca, Bayer, and GlaxoSmithKline, and institutional research grants from Bayer; he serves as Chairperson of the Scientific Advisory Board of the International Aspirin Foundation. The remaining authors declare that they have no conflict of interest.